Radiologically Guided Biopsies of Metastatic Castration Resistant Prostate Cancer to Identify Adaptive Mechanisms of Resistance
The purpose of this study is to better understand how cancer treatment may affect prostate cancer cells.
The research will involve genetic, molecular, cellular, and immunologic experiments using blood and tumor specimens. It is hoped that the information gained from these studies will lead to a greater understanding of castrate-resistant prostate cancer and potentially, improvements in cancer treatment.
Metastatic Prostate Cancer that no longer responds to hormone therapy.
Prostate cancer that has spread outside the prostate and either has recurred after or never responded to hormone therapy.
18 - 100
Healthy Volunteers Needed
Duration of Participation
You will have study visits every 3 months until your cancer stops responding to current therapy (about 6 months to 3 years). We will continue to check on you by telephone for the rest of your life.
Clinical trials Information Line: Phone 503-494-1080 or email@example.com
Stand Up To Cancer-Prostate Cancer Foundation